Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,003 DKK | -0.45% | +1.91% | -7.05% |
03/05 | GENMAB : A good start to 2024; guidance unchanged | |
03/05 | Genmab Posts Q1 Net Profit Surge; Revenue Jumps | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.05% | 18.64B | |
+2.70% | 108B | |
+10.19% | 105B | |
+1.57% | 23.46B | |
-12.24% | 21.72B | |
-37.64% | 17.45B | |
-7.11% | 17.19B | |
+6.35% | 13.99B | |
+35.90% | 12.53B | |
+332.25% | 8.81B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Genmab Looks to Expand Clinical Pipeline with $1.8 Billion Purchase of Cancer-focused ProfoundBio